Obalon Announces Data Presentation at the Annual Meeting of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Obalon Announces Data Presentation at the Annual Meeting of the American Society for Metabolic and Bariatric Surgery

SAN DIEGO, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announced an oral presentation at ObesityWeek 2016 , the largest international event focused on the basic science, clinical application, prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS) .   The presentation, titled “A 6-month Swallowable Balloon System results in sustainable weight loss at 1 year: Results from a prospective, randomized sham-controlled trial” will be presented by Dr. Aurora Pryor at 8:22 am CDT this morning at the meeting in Great Hall B-C. 

“We’re eager for the healthcare professionals on the front lines of fighting obesity to hear first-hand the scientific rigor that exists around our clinical trial, as well as the level of efficacy that our clinical investigators and trial participants experienced with the Obalon Balloon System,” commented Andy Rasdal, Chief Executive Officer of Obalon. “Obesity Week is the premiere meeting to debut this data.”

The Obalon Balloon System was approved by the Food and Drug Administration (FDA) in September 2016. It is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise. Three (3) Obalon Gastric Balloons are placed in the stomach within three months of the six-month treatment period. The Obalon Balloon System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed.

“The Obalon Balloon System, coupled with lifestyle modification, provides a new low risk option for patients struggling with obesity,” said Aurora Pryor, MD, FASMBS, study co-author and Director of the Bariatric and Metabolic Weight Loss Center at the Stony Brook University School of Medicine’s Department of Surgery. “The significant weight loss achieved with the Obalon Balloon System is typically maintained at 12 months, providing patients with an opportunity to maintain a healthier lifestyle.”

In a clinical trial, 387 patients in the United States across fifteen clinical trial sites were randomized in a double-blind, sham-controlled study. The patients in the clinical trial received either three Obalon balloons or three sham placebo-like devices that looked similar to the balloons, but were filled with sugar. The patients in both groups were given minimal diet counseling of 25 minutes every three weeks. Both co-primary weight loss endpoints were met, with approximately 65% of patients who received the Obalon balloon system experiencing clinically meaningful weight loss of at least 5% of their total body weight, which is twice as many people than in the sham-control group. Additionally, patients in the Obalon Balloon System group showed strong weight loss maintenance, with 89.5% of the mean total body weight loss maintained at one year.

About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ: OBLN ), is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit  www.obalon.com .

Forward Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the benefits of the company’s product. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Although the company believes that the expectations reflected in such forward-looking statements are reasonable, the company cannot guarantee future events, results, actions, levels of activity, performance or achievements. Forward-looking statements are subject to risks and uncertainties that may cause the company's actual activities or results to differ significantly from those expressed in any forward-looking statement, including risks and uncertainties related to the company’s ability to achieve or sustain profitability; the company’s ability to predict its future prospects and forecast its financial performance and growth; the rate at which physicians and patients adopt and use the company’s balloon system; the effect of adverse events or other negative developments involving other companies’ intragastric balloons or other obesity treatments; the company’s ability to educate physicians on safe and proper use of the Obalon balloon system; the rate at which patients may experience serious adverse device events as the result of the misuse or malfunction of, or design flaws in, the company’s products; the company’s ability to obtain FDA approval or other regulatory approvals for its future products and product improvements; the company’s ability to adequately protect its proprietary technology and maintain its issued patents and other risks and uncertainties described under the heading "Risk Factors" in documents the company files from time to time with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.

Media: Megan Driscoll EvolveMKD Office Phone: +1 646 517 1565 mdriscoll@evolvemkd.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 6

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 138

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 41

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 179

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 61

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 153

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 114

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 192

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 56

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Market Dynamics: Dollar Strength and Economic Trends

Updated Category News Views 280

Understanding Current Market Trends In today's financial landscape, the dollar has been showing significant strength, propelled largely by the increasing yields of U.S. Treasuries. This upswing marks the dollar reaching levels not seen in nearly three months against both the euro and the yen, signaling contrasting economic conditions across these regions. Economic...

Continue Reading
Bitcoin Surpasses $99K: Insights on Market Movements

Updated Category News Views 245

Bitcoin's Impressive Recovery Journey Bitcoin has displayed remarkable resilience in the market, experiencing gains for the seventh consecutive day with its price hitting $99,513.7. This uptrend comes after a challenging year-end period that saw a significant dip in value. As investors closely monitor the evolving regulatory outlook in the United States under the...

Continue Reading
StoneX Group Inc. Prepares for First Quarter Earnings Release

Updated Category News Views 102

StoneX Group Inc. Prepares for Earnings Release StoneX Group Inc. (NASDAQ: SNEX) is gearing up to share its fiscal 2025 first quarter financial results. This release is scheduled for a date soon to come, creating excitement within the investment community. As a part of its commitment to transparency and investor engagement, the company will host a conference call the...

Continue Reading
Down4Sound Introduces High-Power DVX Subwoofer Series

Updated Category News Views 82

Down4Sound Launches Exciting New DVX Subwoofer Series Down4Sound, a renowned name in high-performance car audio systems, has announced the introduction of their groundbreaking DVX Subwoofer Series. This innovative product line promises to redefine audio experiences for enthusiasts everywhere, boasting a phenomenal 1700W RMS power output across multiple size options to...

Continue Reading
Jozu Boosts AI Deployment Speed and Strengthens Security Efforts

Updated Category News Views 365

Accelerating AI Deployment with Jozu Jozu has unveiled an innovative enterprise AI orchestration platform that significantly reduces the time required for deploying AI applications while enhancing security and compliance protocols. This platform addresses the increasing demands faced by organizations in managing AI applications effectively. Enhancing AI Management Across...

Continue Reading